Advanced Medical Solutions GroupCHIX:AMSL +0.18%93 Return-on-Tangible-Equity is 15.57% as of Dec. 2025, which is 14% below its 10-year median of 18.03. GuruFocus rates CHIX:AMSL with a GF Score™ of 93/100 and a GF Value™ of £3.71 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 758 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks better than 86.02% on this metric.
The historical rank and industry rank for Advanced Medical Solutions Group's Return-on-Tangible-Equity or its related term are showing as below:
CHIX:AMSl'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 8.78 Med: 18.03 Max: 24.93
Current: 24.32
During the past 13 years, Advanced Medical Solutions Group's highest Return-on-Tangible-Equity was 24.93%. The lowest was 8.78%. And the median was 18.03%.
CHIX:AMSl's Return-on-Tangible-Equity is ranked better than 86.02% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.08
vs CHIX:AMSl: 24.32
Advanced Medical Solutions Group (CHIX:AMSl) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Advanced Medical Solutions Group Return-on-Tangible-Equity Related Terms
Advanced Medical Solutions Group Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group Return-on-Tangible-Equity Chart
CHIX:AMSL vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 15.57% mean?
Advanced Medical Solutions Group (CHIX:AMSL) has a Return-on-Tangible-Equity of 15.57% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Advanced Medical Solutions Group and its competitors. This is 14% below median its historical median of 18.03. Over the past decade, Advanced Medical Solutions Group's Return-on-Tangible-Equity has ranged from 8.78 to 24.93. According to the industry distribution chart, Advanced Medical Solutions Group ranks #106 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 14%.
Is Advanced Medical Solutions Group's Return-on-Tangible-Equity too high?
Advanced Medical Solutions Group's current Return-on-Tangible-Equity of 15.57% is 14% below median its 10-year median of 18.03. Over the past 10 years, this metric has ranged from a low of 8.78 to a high of 24.93. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.08. Advanced Medical Solutions Group's value of 15.57% is 281.6% above this industry median. Based on the distribution chart, Advanced Medical Solutions Group ranks #106 out of 758 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Advanced Medical Solutions Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #106 out of 758 companies for Return-on-Tangible-Equity. This places Advanced Medical Solutions Group in the top 14% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.08. Advanced Medical Solutions Group's value of 15.57% is 281.6% above this benchmark. Historically, Advanced Medical Solutions Group's own Return-on-Tangible-Equity has ranged from 8.78 to 24.93 over the past decade. While the company's 10-year median is 18.03 vs. the industry median of 4.08, Advanced Medical Solutions Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.08, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current Return-on-Tangible-Equity of 15.57% is 281.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Advanced Medical Solutions Group and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current Return-on-Tangible-Equity is 15.57%, which is 14% below median its own 10-year median of 18.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.71, compared to a current price of £2.81 — trading 24.4% below its estimated fair value. The current Return-on-Tangible-Equity is 15.57%, which is 14% below median its 10-year median of 18.03 and 281.6% above the Medical Devices & Instruments industry median of 4.08. Advanced Medical Solutions Group's overall GF Score™ is 93/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current Return-on-Tangible-Equity is 15.57% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued.
The current stock price of £2.81 is trading 24.4% below its estimated GF Value™ of £3.71.
GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.
Key valuation signals for CHIX:AMSL:
Return-on-Tangible-Equity: 15.57% (14% below median its 10-year median of 18.03)
GF Value™: £3.71 vs. price of £2.81 (24.4% below fair value)
Industry Position: 281.6% above the Medical Devices & Instruments median (#106 of 758)
No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Medical Solutions Group Business Description
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
93GF Score
Get the complete analysis for CHIX:AMSL
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMSL has been successfully added to your 
